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Secreted proteome of the murine multipotent hematopoietic
progenitor cell line DKmix
Abstract
Administration of the multipotent hematopoietic progenitor cell (HPC) line DKmix improved cardiac
function after myocardial infarction and accelerated dermal wound healing due to paracrine
mechanisms. The aim of this study was to analyse the secreted proteins of DKmix cells in order to
identify the responsible paracrine factors and assess their relevance to the wide spectrum of therapeutic
effects. A mass spectrometry (MS)-based approach was used to identify secreted proteins of DKmix
cells. Serum free culture supernatants of DKmix-conditioned medium were collected and the proteins
present were separated, digested by trypsin and the resulting peptides were then analyzed by
matrix-assisted laser desorption/ionization tandem time-of-flight (MALDI-TOF/TOF) MS. Overall 95
different proteins were identified. Among them, secretory proteins galectin-3 and gelsolin were
identified. These proteins are known to stimulate cell migration and influence wound healing and
cardiac remodelling. The remaining proteins originate from intracellular compartments like cytoplasm
(69%), nucleus (12%), mitochondria (4%), and cytoplasmic membrane (3%) indicating permeable or
leaky DKmix cells in the conditioned medium. Additionally, a sandwich immunoassay was used to
detect and quantify cytokines and chemokines. Interleukin-6 (IL-6), interleukin-13 (IL-13),
monocyte-chemoattractant protein-1 (MCP-1), monocyte-chemoattractant protein-3 (MCP-3),
monocyte-chemoattractant protein-1alpha (MIP-1alpha) and monocyte-chemoattractant protein-1beta
(MIP-1beta) were detected in low concentrations. This study identified a subset of proteins present in
the DKmix-conditioned medium that act as paracrine modulators of tissue repair. Moreover, it suggests
that DKmix-derived conditioned medium might have therapeutic potency by promoting tissue
regeneration.
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Abstract 
 
Administration of multipotent hematopoietic progenitor cell (HPC) line DKmix improved 
cardiac function after myocardial infarction and accelerated dermal wound healing due to 
paracrine mechanisms. The aim of this study was to analyse the secreted proteins of 
DKmix cells in order to identify the responsible paracrine factors and assess their 
relevance to the wide spectrum of therapeutic effects. A mass spectrometry-based 
approach was used to identify secreted proteins of DKmix cells. Serum free culture 
supernatants of DKmix-conditioned medium were collected and the proteins present were 
separated, digested by trypsin and the resulting peptides were then analyzed in a MALDI-
TOF/TOF mass spectrometer. Overall 95 different proteins were identified. Among them, 
secretory proteins galectin-3 and gelsolin were identified. These proteins are known to 
stimulate cell migration and influence wound healing and cardiac remodelling. The 
remaining proteins originate from intracellular compartments like cytoplasm (69%), 
nucleus (12%), mitochondria (4%), and cytoplasmic membrane (3%) indicating permeable 
or leaky DKmix cells in the conditioned medium. Additionally, a sandwich immunoassay 
was used to detect and quantify cytokines and chemokines. Interleukin-6 (IL-6), 
interleukin-13 (IL-13), monocyte-chemoattractant protein-1 (MCP-1), monocyte-
chemoattractant protein -3 (MCP-3), monocyte-chemoattractant protein-1α (MIP-1α) and 
monocyte-chemoattractant protein-1β (MIP-1β) were detected in low concentrations. This 
study identified a subset of proteins present in the DKmix-conditioned medium that act as 
paracrine modulators of tissue repair. Moreover, it suggests that DKmix-derived 
conditioned medium might has the therapeutic potency by promoting tissue regeneration. 
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Introduction 
 
Stem and progenitor cells have been used in preclinical and clinical applications to treat a 
wide range of diseases including heart diseases1-9, accelerate dermal wound healing10-14  
and angiogenesis15-17. The immortalized murine hematopoietic progenitor cell (HPC) line 
DKmix comprises all morphological and phenotypical characteristics of HPCs18. 
Administration of DKmix cells after experimental myocardial infarction reduces infarct 
size and improves left ventricle function and dimensions in a dose-dependent manner. 
This effect was associated with improved angiogenesis and reduced apoptosis in the 
infarct border zone6. Furthermore, it was shown that DKmix cells improve skin-substitute 
wound healing, promote angiogenesis, and induce migration and proliferation of 
fibroblasts14. Interestingly, all these effects were also observed if only the cell-free 
supernatant of the DKmix growth medium (termed DKmix-conditioned medium) was 
applied, indicating paracrine factors secreted by DKmix cells. Preliminary experiments 
provided evidence that cytokines are present in the DKmix-conditioned medium and may 
contribute to the observed paracrine effects14. 
The hypothesis of paracrine mechanisms will introduce an interesting new dimension in 
regenerative medicine. Instead of using cells such as HPCs, biologics secreted by these 
cells could be used to enhance endogenous repair of injured tissue. Such an approach will 
have a great potential for the development of regenerative strategies at affordable costs 
and with better quality control. Furthermore, this will bypass the existing confounding 
issues associated with cell-based therapy i.e. immune compatibility, tumorigenicity [also 
true for biologics], xenozootic infections, and difficulties of ex vivo expansion of 
autologous cell preparations. 
In the present study we analyzed DKmix-conditioned medium to identify all proteins 
liberated by DKmix cells. Among them, those factors responsible for improvement of 
cardiac function after myocardial infarction and dermal wound healing must be present. 
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Materials and Methods 
 
Chemicals 
Trifluor acetic acid was obtained from J.T. Baker (Mallinckrodt Baker, Griesheim, 
Germany). The MS peptide calibration standard and alpha-cyano-4-hydroxy-cinnamic 
acid (CHCA) were purchased from Bruker Daltonics GmbH (Bremen, Germany). 
Chemicals for cell culture were from PAA Laboratories (Pasching, Austria), Cell Systems 
(St. Katharinen, Germany), and Invitrogen GmbH (Karlsruhe, Germany). All other 
chemicals were from Fluka (Sigma-Aldrich GmbH) in the highest purity available. 
 
Cells and Cell Culture 
DKmix cells were propagated as described previously18. In brief, cells were cultivated in 
Iscove’s modified Dulbecco’s medium complete (PAA Laboratories) supplemented with 
10% FCS, 2 mM L-Glutamine, 100 μg/mL penicillin and streptomycin, 1 mM of non-
essential amino acids, 5 x 10-5 M 2-mercaptoethanol, and a stem cell cytokine cocktail 
consisting of 10 ng/mL recombinant murine interleukin-3 (IL-3) and 50 ng/mL 
recombinant murine stem cell factor (SCF) (all from Cell Systems) at 37°C and 5% CO2 in 
a humidified incubation chamber (Satorius). Medium was removed if necessary every day 
and the cells were passaged every three days. 
NIH3T3 fibroblasts were cultivated in Dulbecco's modified essential medium (Biochrom, 
Berlin, Germany) supplemented with 10% FCS, 100 μg/mL penicillin, 100 units/mL 
streptomycin, and 1 mM sodium pyruvate at 37 C and 5% CO2 in a humidified 
incubation chamber (Satorius). Cells were passaged upon confluence. 
The astrocyte cell line F98 was grown in DMEM containing 10% FCS and 100 μg/mL 
penicillin and streptomycin at 37°C in a humidified chamber with an atmosphere 
containing 5% CO2. Confluent cells were washed three to five times with PBS and 
scratched from the culture flask. Subsequently, they were harvested by centrifugation at 
1,200 rpm for 6 min. To prepare protein extracts, cells were harvested at 1,200 rpm for 6 
min and washed at least three times with standard PBS buffer. Cell pellets were stored at -
20°C. After thawing the desired buffer was added and cells were homogenized by 
supersonic treatment in cycles of 20 x 3 sec, at 10% sonic energy using a sonotrode 
(Bandelin Electronic, Berlin Germany). To remove cell debris, lysates were centrifuged at 
13,000 g at 4°C for 30 min. 
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Preparation of DKmix-conditioned medium 
Conditioned medium was generated as follows: DKmix cells were cultured for two days 
under standard conditions. Cells were harvested by centrifugation (1,200 rpm, 6 min) and 
washed three times with prewarmed DMEM without FCS and any other additives. In this 
additive-free medium cells were incubated for additionally 6 hours at 37°C under an 
atmosphere containing 5% CO2 in a humidified incubation chamber. Subsequently, cells 
were removed by centrifugation (1200 rpm, 6 min) and the supernatant was collected and 
terminated DKmix-conditioned medium. 0.1 volume of 100 mM Tris, pH 7.5 and 200 mM 
NaCl was added. The DKmix-conditioned medium was directly used for further 
experiments or stored at -20°C. Ultrafiltration tubes (Amicon Ultra, Millipore) with a cut 
off size of 10,000 Da were used for concentration. Concentrated supernatant was stored in 
aliquots at -20°C too. 
 
Transwell migration assay and basic biochemical techniques 
3T3 fibroblasts were cultured in 75 cm2 cell culture flasks in DMEM for two days. 
Medium was removed and cells were washed three times with DMEM medium without 
FCS and maintained over night in this medium. Cells (3 x 105 in 100 µL) were then plated 
into Transwell cell culture inserts (8 µm pore size; BD Bioscience) in a 24 well plate. The 
lower chamber contained 600 µL DMEM supplemented with either FCS, DKmix-
conditioned medium or cell lysates. After incubation for 5 hours at 37°C under an 
atmosphere containing 5% CO2 in a humidified chamber, cells that had migrated into the 
lower chamber were quantified by counting in a Neubauer counting chamber using an 
inverse microscope (Inverse Fluorescent Microscope Axiovert 200M, Zeiss AG, Jena). 
To prepare crude extracts of 3T3, fibroblasts cells were broken by freezing and unfreezing 
in liquid nitrogen and air, for at least five times. Protein was determined by the method of 
Bradford using bovine serum albumin (BSA) as a standard19. If necessary, proteins were 
precipitated using chloroform/methanol precipitation20. 
 
Statistical analysis 
The percent of migrated cells was compared using two-sided t-tests. Where multiple tests 
were performed, the significance level (0.05) was corrected using the Bonferroni 
Correction. 
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One-dimensional SDS-PAGE of proteins and in-gel tryptic digest 
Proteins were dissolved in an adequate volume of Laemmli sample buffer21 and incubated 
at 95°C for 5 minutes. To alkylate cysteine residues 2 µL of an acrylamid solution (40%) 
were added and the mixture was incubated at room temperature for 30 minutes. Then 
samples were subjected to SDS-PAGE using the Laemmli buffer system. A gradient gel 
from 8.5 – 18% acrylamide was used with a 5% stacking gel. After separation proteins 
were visualized by colloidal Coomassie staining22. The protein-containing gel lane was cut 
into 32 pieces and proteins were destained with 50 mM NH4HCO3 in 50% acetonitrile 
(ACN). After drying the gel pieces with 100% ACN and vacuum evaporation they were 
rehydrated with 100 µL of 4 ng/µL modified trypsin (Promega) in 20 mM NH4HCO3, 
10% ACN. After incubating for one hour on ice, residual trypsin solution was removed 
and substituted by 20 mM NH4HCO3 in 10% ACN. Incubation was carried out over night 
at 37°C. Supernatant was collected and the gel pieces were washed with 50% ACN in 
0,2% TFA for 30 minutes shaking and then shrunk with 100% ACN. All solutions 
containing peptides were collected, combined and dried. Samples were dissolved in 30 µL 
2% ACN in 0.1% TFA for HPLC separation.  
 
LC-MS/MS-Analysis 
Peptide samples were separated in a nano HPLC system by reversed phase 
chromatography using a C18 trap column (PepMap 300 µm x 5 mm, 3 µm, 100 Å, 
Dionex) with a flow rate of 30 µL/min and a C18 separation column (PepMap, C18 
reversed phase material, 75 µm x 150 mm, 3 µm, 100 Å, Dionex) with a flow rate of 250 
nL. Peptides were separated using eluent A (5% ACN in 0.1% TFA) and eluent B (80% 
ACN in 0.1% TFA) with a gradient from 16 to 18% eluent B in 27 minutes, 18 to 24% 
eluent B in 40 minutes, 24 to 40% eluent B in 64 minutes and 40 to 80% eluent B in 10 
minutes. Fractions of 90 nL were spotted using a microfraction collector (Probot) directly 
onto a pre-spotted MALDI target plate with a collinear sheath flow of 2.5 µL/min 5% 
ACN, 0.1% TFA aqueous solution. To prepare the MALDI target plate 0.6 µL of a matrix 
solution (4 mg/mL CHCA in 50% ACN, 0.1% TFA and 10 mM NH4H2PO4, diluted 1:4 
with ethanol) had been spotted on each spot of an Anchor target plate (600/384 Bruker 
Daltonik). 0.3 µL of peptide calibration standard (Bruker Daltonik) was used for external 
calibration. Recrystallization was done with 0.2 µL of 0.1% TFA in ethanol. MS and 
MS/MS spectra were generated in an Ultraflex TOF/TOF I (Bruker Daltonik) mass 
spectrometer. 
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Data Analysis 
For protein identification a Mascot search was performed. Therefore MS/MS-spectra were 
matched with the MSDB database released in April 27th 2007. Search parameters for 
mass tolerance were set to 100 ppm for precursor ions and 0.7 Da for fragment ions with 
one allowed missed trypsin cleavage. Proteins were rated identified if at least two peptides 
were identified and the protein identification score was above 60.  
 
Sandwich immunoassay 
A commercially available sandwich immunoassay to detect the murine cytokines and 
chemokines interferon-gamma (IFN-gamma), interleukin-17 (IL-17), interleukin-2 (IL-2), 
interleukin-6 (IL-6), interleukin-5 (IL-5), interleukin-1α (IL-1α), granulocyte macrophage 
colony-stimulating factor (GM-CSF), interleukin-10 (IL-10), interleukin-4 (IL-4), tumor 
necrosis factor (TNF), interleukin-12p70 (IL-12p70), interleukin-13 (IL-13), monocyte-
chemoattractant protein-1 (MCP-1), monocyte-chemoattractant protein-3 (MCP-3), 
RANTES (acronym for “regulated on activation, normal T expressed and secreted”), 
Macrophage inflammatory protein 1-α (MIP1-α), and Macrophage inflammatory protein 
1-β (MIP1-β) was used (FlowCytomix, Bender MedSystems, San Bruno, CA, USA) 
according to the manufacturer’s instructions. Briefly, antibody-coated beads were 
incubated with the samples or recombinant cytokine/chemokine proteins for 
standardization. After intensive washing biotin conjugated secondary antibodies and 
streptavidin-phycoerythrin were added followed by a second incubation. Finally washed 
beads were analyzed by flow cytometry (FACS Canto, BD Pharmingen). Bead 
populations specific for individual cytokines/chemokines were differentiated by their sizes 
and distinct spectral signature. Concentrations of cytokines/chemokines were evaluated 
assessing the phycoerithin fluorescence intensities of the individual bead populations. 
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Results 
 
Production of DKmix-conditioned medium 
To prepare DKmix-conditioned medium, cells were grown for at least two days and 
washed with standard medium free of FCS and other supplements. DKmix cells were 
incubated in this supplement-free medium for different times. Optimal DKmix-
conditioned medium as determined by stimulation of migration/proliferation of fibroblasts 
using the transwell migration assay; the optimum incubation time was obtained after 6 h 
of incubation (data not shown). DKmix-conditioned medium stimulated the migration and 
proliferation of 3T3 fibroblasts to a similar extent as FCS did that was used as positive 
control (Fig. 1A, B). Concentrated DKmix-conditioned medium exhibited similar values 
in the transwell migration assay indicating that this assay did not produce quantitative 
results or the maximum effect was reached allowing no further stimulation (data not 
shown). Dilution of the concentrated medium to the initial concentration did not result in 
loss of migratory activity, but further dilution led to a decrease of activity (data not 
shown). Concentration of DKmix-conditioned medium was done using a cut off of 10,000 
Da and all activity resided in the high molecular weight fraction, but no stimulating 
activity was detected in the smaller molecular weight fraction. Furthermore, migration 
inducing activity was inactivated by heat and was strongly reduced by trypsin treatment 
indicating the proteinaceous nature of migration stimulating activity (Fig. 1C). Also, crude 
lysates of DKmix cells stimulated the migration of fibroblasts in a protein concentration-
dependent manner underlining that active factors were in fact associated with these cells 
(Fig. 1D). However, crude extracts from other cell lines like 3T3 fibroblasts and neuronal 
F98 cells did not stimulate the migration of fibroblasts even if high protein concentrations 
were applied (Fig. 1E). 
 
 
Identification of proteins present in DKmix-conditioned medium by LC-MS/MS 
In order to identify as many proteins present in the DKmix-conditioned medium as 
possible, large amounts of medium were collected and concentrated by about 100-fold. 
For high resolution protein identification the workflow depicted in Fig. 2 was applied. An 
aliquot of the DKmix-conditioned medium containing 200 μg of proteins was separated by 
SDS-PAGE (Fig. 3). The gel lane was cut into 32 pieces and proteins were treated with 
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trypsin. The generated peptides were extracted, separated by means of reversed phase 
chromatography and spotted onto a MALDI target plate and analyzed. A total of 95 
different proteins were identified in the DKmix-conditioned medium (Table 1). The most 
intense bands on the gel in the region of 70 kDa consisted of heat shock cognate 71 kDa 
protein and transketolase. Both proteins were identified by MS/MS spectra of 20 and 10 
peptides, respectively and high mascot scores were obtained for both. The intense band at 
17 kDa was identified to be peptidyl-prolyl cis/trans isomerase A and the intense band at 
14 kDa comprises mainly core histones. Four of the identified proteins are known to be 
secreted by cells: galectin-3, gelsolin, inter-α-trypsin inhibitor heavy chain H, and Loss of 
Heterozygosity A protein. Galectin-3 and gelsolin are known stimulators of cell migration 
and are involved in tissue repair and cardiac remodelling27-37. Both should contribute to 
migration stimulating activity. The other identified proteins are not known to be secreted 
by cells. Since they are present in DKmix-conditioned medium they are here categorized 
depending on their location and function. Most of the identified proteins were of 
cytoplasmic (69%), nucleic (12%), and mitochondrial (4%) origin. A smaller part derived 
from the membrane (3%) and the ribosomes (2%) (Fig. 4A). All identified proteins were 
categorized into 9 different groups according to their function (Fig 4B). The other 
identified proteins were involved in metabolic/catabolic activities and in defence response 
processes. Only a few of the identified proteins were involved in cellular events like cell 
cycle, cell migration, tissue differentiation and physiological processes. However, a 
significant number (6%) of proteins were involved in apoptotic processes. 
 
Identification of cytokines and chemokines in DKmix-conditioned medium 
A sandwich immunoassay that detects murine cytokines and chemokines was used to 
analyze concentrated DKmix-conditioned medium. In this assay 18 different cytokines 
and chemokines were analyzed in parallel and the concentration of each was calculated 
using an internal standard based on recombinant cytokines or chemokines. The DKmix-
conditioned medium was concentrated by about 150 times and the cytokines and 
chemokines IL6, IL13, MCP-1, MCP-3, MIP-1α and MIP-1β were detected (Table 2). The 
concentration of cytokines and chemokines varied from 13 pg/mL for MIP1-β that is close 
to the detection limit to 3170 pg/ml for MCP-1 in concentrated DKmix-conditioned 
medium. Considering the concentration factor of the DKmix-conditioned medium that has 
been used, the concentration of the identified factors in the non-concentrated DKmix-
conditioned medium varied between 0.1 and 21 pg/mL. 
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Discussion 
 
Stem and progenitor cells have been used in experimental and clinical trials to treat a wide 
range of diseases23-24. However, the underlying mechanisms remain unclear. There is 
increasing evidence that therapeutic effects of cell therapy may be mediated by paracrine 
factors25. Therefore, identification of secreted factors will improve our knowledge on 
beneficial effects of stem and progenitor cells. Factors present in a DKmix-conditioned 
medium have been successfully used in treatment of experimentally induced infarcts and 
in wound healing6,14. 
The withdraw of serum and supplements before generation of DKmix-conditioned 
medium was necessary to avoid paracrine effects that might be induced by medium 
supplements like fetal calf serum and/or growth factors. However, it cannot be excluded 
that removal of medium components modifies the protein expression pattern and might 
induce formation of paracrine factors. Crude extracts of DKmix cells grown in standard 
medium exhibited stimulating effects in the migration assay and other cell lines did not. 
This indicated that similar factors were expressed under standard and experimental growth 
conditions and their isolation should be easier from the supernatant than from crude 
extract due to the lower complexity. The secretion of proteins by stem and progenitor cells 
in vitro that exhibit paracrine effect is consistent with the hypothesis that paracrine factors 
could mediate tissue repair and regeneration observed after cell transplantation. However, 
validation of the hypothesis will require demonstration that transplanted cells in vivo also 
secrete a similar spectrum of proteins that could support tissue repair and regeneration. 
Patterns of secreted factors expressed by cells that undergo experimental or clinical 
transplantation and cells that are retained in the infarcted or injured area may be somewhat 
different. But so far it is unknown which secreted factors are produced by DKmix cells in 
the heart after intracoronary transfer or in dermal wounds. As recently observed after 
endothelial progenitor cell transplantation in a mouse model of acute myocardial 
infarction, transplanted cells may stimulate resident cells to produce additional secreted 
factors26. 
The methods used to analyze the protein present in the DKmix conditioned medium are 
quite different but do have equal quality for sample analysis. However, the sandwich assay 
is more sensitive than the used MS approach but the MS approach can detect all proteins 
and not only a predefined known subset. Both methods might be useful to perform a 
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differential screening of e. g. supernatants from cell entities that exhibit paracrine effects 
and those cells that do not. Proteins that are solely identified in the supernatant of cells 
with paracrine effects might be considered as positive acting paracrine factors. 
In this study we provide evidence that the paracrine activity of DKmix-conditioned 
medium was sensitive to heat and endoprotease treatment and thus is of proteinaceous 
quality; the molecular mass is >10 kDa and soluble low molecular weight compounds 
were not involved. Proteins present in the DKmix-conditioned medium were identified by 
two strategies: I, a highly comprehensive MS-based approach and II, an immunological 
approach. Overall 95 different proteins (Table1) were identified in the MS-based approach 
whereas the cytokines IL-6 and IL-13 and the chemokines MCP-1, MCP-3, MIP1-α, and 
MIP1-β were identified using the immunological approach. No chemokines and cytokines 
were detected by the MS approach most likely due to their low concentration in the 
DKmix-conditioned medium. The chemokine detected with the highest concentration was 
MCP-1 (3000 pg/ml) whose amount of less than 10 fmol in the MS-analyzed sample is 
below the detection limit of the MS analysis. 
The proteins galectin-3, gelsolin, inter-α-trypsin inhibitor heavy chain H, and Loss of 
heterozygosity A protein are known to be secreted by cells. Galectin-3 is involved in a 
variety of biological functions, including cell proliferation, migration and differentiation, 
tumor cell adhesion, angiogenesis, tumor progression and metastasis interacting with 
DMBT1 and α3- and β1-integrins27,28. The galectin-3 gene is also up-regulated by human 
endothelial progenitor cells compared with three differentiated endothelial cells29. It 
stimulates cell migration and wound healing in mice and pigs28,30 and induces TGF-β, 
interleukins-1 and -2. In wound healing the central process is re-epithelialization, which is 
dependent on cell migration, stimulated by Galectin-328. Thus, it seems likely that 
stimulation of cell migration and wound healing are supported by the galectin-3 present in 
DKmix-conditioned medium. Galectin-3 triggers cardiac remodelling and evokes 
fibroblast proliferation, collagen deposition and ventricular dysfunction in rat hearts31. 
Furthermore, galectin-3 induces cardiac remodelling impairing heart function28,31 and is a 
marker of heart failure and is prognostic with adverse outcome32,33. This is in overt 
contrast to the beneficial effects of DKmix-conditioned medium on hearts after 
myocardial infarction6. However, these opposite effects might be due to different 
concentrations of galectin-3 or can be explained by the presence of additional paracrine 
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factors in a DKmix-conditioned medium that lead to an overall regenerating effect on 
heart tissue. 
Gelsolin is known to be present in the cytoplasm of different cells and is secreted into 
human plasma, exhibiting nearly identical structures in both compartments. It is a protein 
associated with migration and proliferation; it is regulated by calcium, which is involved 
in actin modulation. It binds to actin filament ends and mediates cell migration in 
keratinocytes and fibroblasts34,35. Gelsolin is a pivotal molecule in EGF-stimulated 
fibroblast migration and is down-regulated in early phase healing of human burn wounds 
when scar formation has not commenced. Furthermore, the function of gelsolin is 
described to be pro- as well as anti-apoptotic36. The C-terminal half of gelsolin can 
prevent apoptosis by blocking voltage-dependent anion channels, inhibiting mitochondrial 
membrane potential loss and cytochrome c release37,38. The function of gelsolin in human 
plasma is not clearly defined and it has been suggested that it functions as an actin 
scavenging system or as a carrier of inflammatory mediators39. Gelsolin has also been 
shown to bind bacterial lipopolysaccharides and might mediate or inhibit endotoxin effects 
in vivo39. The presence of gelsolin in the DKmix conditioned medium might be due to 
secretion of the protein into the culture supernatant and by cell lysis that occurred during 
generation of DKmix-conditioned medium. Although gelsolin is involved in processes 
stimulated by the DKmix-conditioned medium it is not evidently clear how the protein 
promotes cell migration, wound healing, or cardiac regeneration after extracellular 
application. Possibly, gelsolin functions as a carrier of inflammatory mediators and might 
thus be involved in tissue regeneration and cell migration. Several factors were identified 
in the DKmix-conditioned medium by the LC-MS approach, which are involved in actin 
integrity and thereby influence cell migration (Table 1): actin, coactosin-like protein, γ-
actin-like protein, macrophage-capping protein, Rho GDP-dissociation inhibitor 2, smooth 
muscle γ-actin, transgelin-2, 40S ribosomal protein SA, 40S ribosomal protein S19. 
However, these proteins act only intracellularly and so far, it is unknown whether they are 
responsible for processes such as enhanced wound healing. However, further studies are 
necessary to investigate and confirm these findings. 
Trypsin inhibitor H2 is a transport protein for hyaluronan40, which is a main component of 
the extra cellular matrix. This protein is involved in proliferation and migration of cells 
and might act as a positive factor in wound healing and cell migration in mediating 
hyaluronan supply. No evidence is available from the literature for Loss of heterozygosity 
A protein that it might be involved in processes such as tissue repair. 
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The identified cytokines IL-6 and IL13 as well as the identified chemokines MCP-1, 
MCP-3 and MIP1-α and MIP1β  modulate cellular responses by activation and 
recruitment of immune cells mediating host cellular and tissue remodeling and thus should 
be mainly involved in attracting cells, wound healing and myocardial regeneration41. 
However, the concentrations of these factors were strikingly low with values between 0.1 
and 21 pg/mL in the non-concentrated DKmix-conditioned medium. Only IL-13 (10.7 
pg/mL) and MCP-1 (21.1 pg/mL) were detected in significant concentrations sufficient to 
provide beneficial effects on wound healing and tissue regeneration after myocardial 
infarction. 
The other proteins identified in the MS approach are not reproted to possess cell migration 
stimulating activity and are not involved in regeneration after myocardial infarction. They 
belong to the highly abundant proteins present in cells and should be present in DKmix-
conditioned medium because of cell permeability. However, only few intracellular 
proteins were identified as compared to proteome analysis of complete cellular extracts 
using the same methodology42 and a lot of highly abundant cytoplasmic proteins were not 
identified that are actually detectable in cell lysates. This indicates that the release of 
intracellular proteins is somehow selective and only particular proteins are present in the 
culture supernatant. This should not be the case if solely unspecific cell lysis was 
reponsible for cytoplasmic proteins present in DKmix-conditioned medium.  
Some of the identified proteins have more than one function and have been designated as 
moonlighting proteins29,43. Glucose-6-phosphate isomerase is described to act as a 
metabolic enzyme but is also described as neuroleukin or autocrine motility factor (AMF) 
acting as a neurotrophic factor for spinal and sensory neurons affecting cell migration and 
proliferation43. A similar function might be assumed for this protein in wound healing, cell 
migration and regeneration after myocardial infarction. Additionally, more of the 
identified proteins present in the DKmix-conditioned medium in high concentrations 
might have additional (moonlighting) functions and stimulate tissue repair. These factors 
are specific for DKmix cells because no activity enhancing cell migration has been 
identified in crude extracts of F98 and 3T3 fibroblasts cells. 
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Conclusion 
 
In conclusion, our analysis of the secreted proteome of the hematopoietic progenitor cell 
line DKmix revealed a set of proteins among them chemokines and cytokines, which exert 
modulating effects on tissue repair and regeneration, and therefore provide molecular 
support for a hematopoietic progenitor cell mediated paracrine effect in transplantation 
studies. The array of identified factors in DKmix supernatant suggest rather a cooperative 
mode of action than the individual activity of a single factor. Therefore, our elucidation of 
the conditioned medium of hematopoietic progenitor cells is very relevant to the 
translation of cell-based biologics toward clinical applications. 
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Figures Legends 
 
Figure 1: Both DKmix-conditioned medium and cell lysate of DKmix cells enhance 
migration of fibroblasts in vitro. 
Migration of 3T3 fibroblasts was carried out in the absence (negative control) and in the 
presence of 10% FCS (positive control). **P < 0.01; *P < 0.05; n.s. = not significant. 
(A) The migration assay was performed with 10% DKmix-conditioned medium (n = 9 
each group). 
(B) Example of a transwell migration assay. The cells present on the filters were made 
visible with DAPI staining of nuclei and microscopy (125-fold magnification). The upper 
picture shows a negative control sample, the lower picture a positive control where cell 
migration was stimulated with FCS. 
(C) DKmix-conditioned medium was inactivated by heat or trypsin treatment. Migration 
was carried out with 10% inactivated DKmix supernatant (n = 4 each group). 
(D) Cells were broken by a cycle of freezing and thawing. Migration was analyzed with 
DKmix cell lysate ( a) 7,5 μg protein, b) 2,5 μg protein, c) 0,78 μg protein and d) 0,26 μg 
protein) (n = 2-4 per group). 
(E) Cells were broken by a cycle of freezing and thawing. Migration was carried out in the 
presence of 10% of different cell lysates (n = 3-5 per group). 
 
Figure 2: Workflow 
DKmix-conditioned medium was prepared and fractionated by SDS-PAGE. The gel lane 
was cut into 32 slices [pieces as used in the Result section], which were then in-gel 
digested with trypsin. The peptide mixture was separated by reversed phase 
chromatography followed by MALDI-MS/MS analyses. Obtained MS data were searched 
against the Mascot protein sequence data base. 
 
Figure 3: DKmix supernatant protein separation by one-dimensional SDS gel 
200 µg of protein were separated by SDS-PAGE on a 8.5-18% gradient gel. Proteins were 
stained by colloidal Coomassie and cut into 32 pieces for further LC-MS analysis. 
 
Figure 4: Proteins identified in the LC-MS approach were grouped by cellular 
compartments (Figure 4A) and biological processes (Figure 4B). 
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Table 1: Proteins identified in DKmix-conditioned medium using LC-MS/MS 
No Protein Name Acc.-No1 Score2 MW3 Pep4 Local5 
1 Galectin-3 P16110 108 27,4 2 Secreted 
2 Gelsolin P13020 130 80,8 2 Secreted 
3 α-trypsin inhibitor heavy chain H2 Q61703 157 106,2 3 Secreted 
4 Loss of heterozygosity A protein Q99KC8 63 87,1 2 Secreted 
5 14-3-3 protein beta/alpha Q9CQV8 114 27,94 3 Cytoplasm 
6 14-3-3 protein epsilon P62259 104 29,17 3 Cytoplasm 
7 14-3-3 protein gamma P61982 217 28,2 4 Cytoplasm 
8 14-3-3 protein zeta/delta P63101 204 27,8 4 Cytoplasm 
9 6-phosphogluconolactonase Q9CQ60 107 18,3 2 Cytoplasm 
10 Actin, alpha cardiac muscle 1 P68033 506 42,0 12 Cytoplasm 
11 Actin, cytoplasmic 1 P60710 826 41,7 17 Cytoplasm 
12 Adenine phosphoribosyl transferase Q6PK77 141 19,7 3 Cytoplasm 
13 Aldehyde dehydrogenase P47739 135 50,4 4 Cytoplasm 
14 Alpha-enolase P17182 564 47,0 10 Cytoplasm 
15 Aspartate aminotransferase P05201 378 46,1 9 Cytoplasm 
16 Aspartate aminotransferase Q3UJH8 352 46,2 8 Cytoplasm 
17 Beta-enolase P21550 131 46,9 3 Cytoplasm 
18 Bromodomain containing protein  Q921C3 61 253,6 2 Cytoplasm 
19 Coactosin-like protein Q9CQI6 71 15,8 2 Cytoplasm 
20 Cytosol aminopeptidase Q9CPY7 62 52,6 2 Cytoplasm 
21 Elongation factor 1-gamma Q9D8N0 132 49,9 4 Cytoplasm 
22 Ferritin light chain 1 P29391 252 20,7 4 Cytoplasm 
23 Flavin reductase Q923D2 232 22,1 4 Cytoplasm 
24 Fructose-bisphosphate aldolase A P05064 696 39,3 12 Cytoplasm 
25 Gamma actin-like protein Q9QZ83 180 43,6 5 Cytoplasm 
26 Glucose-6-phosphate isomerase P06745 379 62,7 7 Cytoplasm 
27 Glutathione peroxidase 1 P11352 127 22,3 2 Cytoplasm 
28 Glutathione S-transferase P 1 P19157 148 23,5 3 Cytoplasm 
29 Glutathione transferase omega-1 O09131 108 27,5 2 Cytoplasm 
30 Glyceraldehyde-3-phosphate DH P16858 76 35,8 2 Cytoplasm 
31 Guanine nucleotide binding protein Q5NCC6 171 16,3 3 Cytoplasm 
32 Heat shock cognate 71 kDa protein P63017 1126 70,8 20 Cytoplasm 
33 Heat shock protein HSP 90-alpha P07901 164 64,7 4 Cytoplasm 
34 Heat shock protein HSP 90-beta P11499 176 83,2 5 Cytoplasm 
35 Hsp a8 protein Q3KQJ4 102 62,1 2 Cytoplasm 
36 Keratin, type I cytoskeletal 10 P02535 113 57,7 3 Cytoplasm 
37 Keratin, type I cytoskeletal 13 P08730 74 47,7 2 Cytoplasm 
38 Keratin, type II cytoskeletal 1 P04104 99 59,7 2 Cytoplasm 
39 Keratin, type II cytoskeletal 1b Q6IFZ6 107 0,0 2 Cytoplasm 
40 Keratin, type II cytoskeletal 5 Q922U2 61 62,8 2 Cytoplasm 
41 Keratin, type II cytoskeletal 6B Q9Z331 97 60,2 2 Cytoplasm 
42 Keratin, type II cytoskeletal 73 Q6NXH9 84 58,9 2 Cytoplasm 
43 Leukocyte elastase inhibitor A Q9D154 245 39,0 5 Cytoplasm 
44 L-lactate dehydrogenase A chain P06151 183 36,5 5 Cytoplasm 
45 Macrophage-capping protein P24452 98 38,7 3 Cytoplasm 
46 NAD(P)H dehydrogenase 1 Q64669 144 30,8 3 Cytoplasm 
47 Nucleoside diphosphate kinase B Q01768 272 17,4 7 Cytoplasm 
48 Peptidyl-prolyl cis-trans isomerase A P17742 745 18,0 16 Cytoplasm 
49 Peroxiredoxin-1 P35700 195 22,1 4 Cytoplasm 
50 Peroxiredoxin-2 Q61171 96 21,6 3 Cytoplasm 
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 Protein Name Acc.-No1 Score2 MW3 Pep4 Local5 
51 Peroxiredoxin-6 O08709 289 24,7 6 Cytoplasm 
52 Phosphatidylethanolamine-binding 
protein P70296 186 20,7 2 Cytoplasm 
53 Phosphoglycerate kinase 1 P09411 308 44,4 7 Cytoplasm 
54 Phosphoglycerate mutase 1 Q9DBJ1 442 28,7 6 Cytoplasm 
55 Profilin-1 P62962 382 14,8 7 Cytoplasm 
56 Proteasome activator complex P97372 72 26,9 2 Cytoplasm 
57 Proteasome beta-subunit C5 Q6RI64 68 26,4 2 Cytoplasm 
58 Proteasome subunit beta type-2 Q9R1P3 85 22,9 2 Cytoplasm 
59 Pyridoxal kinase Q8K183 89 35,0 2 Cytoplasm 
60 Rho GDP-dissociation inhibitor 2 Q61599 94 22,7 3 Cytoplasm 
61 Smooth muscle gamma-actin Q61852 173 42,9 5 Cytoplasm 
62 Thioredoxin reductase 1 Q9JMH6 86 54,5 2 Cytoplasm 
63 Transaldolase Q93092 114 37,4 3 Cytoplasm 
64 Transgelin-2 Q9WVA4 144 22,4 4 Cytoplasm 
65 Transketolase P40142 551 67,5 10 Cytoplasm 
66 Translation-controlled tumor protein P63028 99 19,4 2 Cytoplasm 
67 Triosephosphate isomerase P17751 545 26,7 8 Cytoplasm 
68 Ubiquitin P62991 319 8,6 5 Cytoplasm 
69 Ubiquitin-conjugating enzyme E2  P61089 143 17,1 3 Cytoplasm 
70 Neutral alpha-glucosidase AB Q8BHN3 62 49,4 2 ER 
71 Peptidyl-prolyl cis-trans isomerase B P24369 200 22,7 5 ER 
72 Aminopeptidase N P97449 80 109,5 2 Membrane 
73 Plexin domaincontaining protein 2 Q9DC11 60 59,6 2 Membrane 
74 Ras-related protein Rab-11B P46638 91 21,8 3 Membrane 
75 Aldehyde dehydrogenase P47738 109 56,6 2 Mitochondrion
76 Aspartate aminotransferase P05202 81 47,2 2 Mitochondrion
77 Citrate synthase Q9CZU6 94 51,7 2 Mitochondrion
78 Dutp protein Q8VCG1 83 17,4 2 Mitochondrion
79 Glutathione reductase P47791 129 52,7 2 Mitochondrion
80 Malate dehydrogenase P08249 413 35,6 8 Mitochondrion
81 Adenosine kinase P55264 64 16,6 2 Nucleus 
82 Cofilin-1 P18760 121 18,4 2 Nucleus 
83 Histone H2A type 1-E P28001 95 14,0 2 Nucleus 
84 Histone H2A type 1-K Q8CGP7 103 14,0 2 Nucleus 
85 Histone H2B type 1-B Q64475 358 13,8 8 Nucleus 
86 Histone H2B type 1-M P10854 119 13,8 3 Nucleus 
87 Histone H3.1 P68433 108 15,3 2 Nucleus 
88 Histone H4 P62806 386 11,4 7 Nucleus 
89 Selenium-binding protein 1 P17563 108 52,5 4 Nucleus 
90 SH3 domain-binding protein Q9JJU8 66 12,7 2 Nucleus 
91 p53-binding protein P70399 61 0,0 2 Nucleus 
92 Zinc finger protein  Q9DB38 64 18,8 2 Nucleus 
93 40S ribosomal protein S19 Q9CZX8 107 16,1 2 Ribosome 
94 40S ribosomal protein SA P14206 127 32,6 2 Ribosome 
95 Gag-pro-pol polyprotein Q1KYL9 62 0,0 2 unknown 
 
1swissprot accession No; 2Macot Score; 3molecular weight in kda; 4No of MS/MS-
identified peptides; 5localization of the protein 
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Table 2: Ctyokine/chemokine concentrations in DKmix-conditioned medium 
Cytokine/Chemokine  Concentrated DKmix-
conditioned medium (pg/ml)
DKmix-conditioned medium 
(pg/ml) 
IL-6 560 4 
IL-13 1600 11 
   
MCP-1 3170 21 
MCP-3 120 1 
MIP1-α 140 1 
MIP1-β 13 0.1 
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